Parkside Financial Bank & Trust
BankPosition in BCRX — Biocryst Pharmaceuticals Inc
CIK 1455267
SAINT LOUIS, MO
Position in BCRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,913
+$759 QoQ
Shares Held
201
+35.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $710,584 across 30 Drug Manufacturers - Specialty & Generic names. BCRX ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
12,038 | $162,632 | |
| 2 | ZTS |
Zoetis Inc.
|
1,074 | $126,956 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,147 | $86,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
136 | $80,644 | |
| 5 | HLN |
Haleon plc
|
5,178 | $51,831 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,560 | $47,411 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,704 | $40,775 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
425 | $21,967 |
All Filings in BCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,913 | 201 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,154 | 148 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,525 | 201 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,675 | 187 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $525 | 70 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||